[Oral triethylene melamine therapy of malignant lymphogranuloma and related conditions].
D006402:Hematologic Diseases; D006689:Hodgkin Disease; D008208:Lymphatic System; D009369:Neoplasms; D014265:Triethylenemelamine / Q000627:therapeutic use*
D014265:Triethylenemelamine
BLOOD/diseases; LYMPHATIC SYSTEM/neoplasms; TRIETHYLENE MELAMINE/therapeutic use
Behandeling van lymphogranuloma malignum en verwante toestanden met tri-aethyleen-melamine per os.